Point72 Asset Management L.P. Acquires 33,507 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Point72 Asset Management L.P. lifted its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 210.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,400 shares of the company's stock after purchasing an additional 33,507 shares during the period. Point72 Asset Management L.P. owned 0.18% of Establishment Labs worth $2,138,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in Establishment Labs by 11.8% in the first quarter. Vanguard Group Inc. now owns 77,798 shares of the company's stock worth $3,960,000 after buying an additional 8,210 shares during the period. California State Teachers Retirement System raised its holdings in Establishment Labs by 14.5% in the first quarter. California State Teachers Retirement System now owns 17,096 shares of the company's stock worth $870,000 after purchasing an additional 2,167 shares in the last quarter. SG Americas Securities LLC purchased a new position in Establishment Labs during the second quarter valued at $303,000. Stableford Capital II LLC boosted its holdings in shares of Establishment Labs by 36.6% during the 2nd quarter. Stableford Capital II LLC now owns 42,102 shares of the company's stock valued at $2,001,000 after buying an additional 11,287 shares in the last quarter. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new stake in shares of Establishment Labs in the 2nd quarter worth about $373,000. Institutional investors own 72.91% of the company's stock.

Establishment Labs Stock Up 0.9 %

Shares of NASDAQ ESTA traded up $0.40 during midday trading on Tuesday, hitting $43.67. The stock had a trading volume of 54,063 shares, compared to its average volume of 384,729. The company has a market cap of $1.22 billion, a P/E ratio of -16.77 and a beta of 1.16. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The business's 50 day moving average is $43.44 and its 200-day moving average is $44.26. Establishment Labs Holdings Inc. has a 52 week low of $22.05 and a 52 week high of $60.12.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Stephens raised shares of Establishment Labs to a "strong-buy" rating in a research report on Monday, December 2nd. Citigroup lifted their target price on shares of Establishment Labs from $45.00 to $50.00 and gave the company a "neutral" rating in a report on Tuesday, October 1st. Finally, BTIG Research upped their price target on Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Establishment Labs currently has an average rating of "Buy" and a consensus target price of $60.60.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.